![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
TxCell presents final positive results of the phase I/II clinical trial with antigen-specific Treg...
TxCell SA, a biotechnology company developing Treg cell-based immunotherapies for the treatment of severe chronic...
AstraZeneca and Forest Laboratories to initiate phase III clinical trials for ceftazidime/avibactam to treat...
AstraZeneca and Forest Laboratories, Inc. announced today that ceftazidime/avibactam (CAZ-AVI) will enter phase III trials...
First results from ongoing Phase III trial show malaria vaccine candidate, RTS,S* reduces the...
First results from a large-scale Phase III trial of RTS,S, published online today in...
Acetylon Pharma starts treating patients in Phase 1-2a multiple myeloma drug trial
Acetylon Pharmaceuticals has started treating patients in a three-part Phase 1-2a trial to evaluate...
Neurocrine starts tardive dyskinesia drug Phase II trial
US based Neurocrine Biosciences has started a second double-blind, placebo controlled, randomized cross-over Phase...
Bionor Pharma to initiate HIV Vacc-4x combination trial
Bionor Pharma is set to initiate a double blinded, randomized and placebo-controlled trial to evaluate...
Scancell updates on cancer vaccine Phase I clinical trial
The Cohort Review Committee has approved Scancell to further escalate cancer vaccine SCIB1 dose to...
Aeras, OETC commence TB drug Phase IIb trial
Aeras and the Oxford-Emergent Tuberculosis Consortium (OETC) have commenced a Phase IIb trial to investigate...
Alnylam concludes liver cancer drug Phase I trial
US based drug developer Alnylam Pharmaceuticals has concluded an open label, multi-center, dose escalation Phase...
Sinapis Pharma concludes Phase I stroke drug trial
Sinapis Pharma has concluded first Phase I clinical trial of oral and IV administration of...